首页> 外文OA文献 >Reimbursement processes – An analysis of international practice models for maintaining the health benefit baskets of solidly financed health care systems
【2h】

Reimbursement processes – An analysis of international practice models for maintaining the health benefit baskets of solidly financed health care systems

机译:报销流程–分析国际惯例模型以维持稳固融资的医疗体系的健康权益篮子

摘要

In view of increasing health care costs and budgetary problems, a systematic reimbursement decision process for medical technologies becomes an important instrument of allocation. Coverage decisions have monetary impact on patients and service providers, and at the same time they implicitly decide whether a technology is implemented and more evidence can be gained. In Austria an overall catalogue of outpatient medical care has been worked on and will need a consistent process for maintenance and further development. Within this context, international practice models of reimbursement processes and their features are analyzed so that critical success factors can be derived. Via hand search on websites and in databases, completed by a systematic literature search, application processes for reimbursement of medical interventions and associated literature has been identified. The criterion for including a country/process was the availability of English, German, or French templates/guidelines for external application. The templates were categorized according to the information domains of the EUnetHTA core model, the funding processes were analyzed regarding to phases and characteristics. The following processes have been analyzed: Australia (MSAC), Denmark (mini-HTA), Spain (GANT), Germany (G-BA, KBV innovation service), England (NICE single technology appraisal), France (HAS application form for medical procedures), Switzerland (BAG) and Austria (MEL, OÖGKK). From the 8 identified and specified country models, Germany, France and Switzerland, which are to some degree comparable to the Austrian health care system, and additionally the Austrian pharmaceutical funding process, have been analyzed according to the process phases (topic selection, assessment, appraisal, decision, implementation) and –aspects (structures, decision criteria, dealing with evidence, stakeholder involvement, communication of results, etc.).
机译:鉴于医疗保健成本增加和预算问题,针对医疗技术的系统性报销决策程序已成为重要的分配工具。承保范围的决定会对患者和服务提供商产生金钱上的影响,同时隐含地决定是否实施一项技术并可以获取更多证据。在奥地利,已经制定了整体门诊医疗目录,将需要一个一致的过程进行维护和进一步发展。在此背景下,对报销流程及其功能的国际惯例模型进行了分析,以便得出关键的成功因素。通过在网站上和数据库中进行手工搜索,并通过系统的文献搜索来完成,已经确定了报销医疗干预和相关文献的申请程序。包含国家/地区/流程的标准是可以使用英语,德语或法语的模板/指南来进行外部应用。根据EUnetHTA核心模型的信息域对模板进行了分类,并根据阶段和特征分析了融资过程。分析了以下过程:澳大利亚(MSAC),丹麦(mini-HTA),西班牙(GANT),德国(G-BA,KBV创新服务),英国(NICE单一技术评估),法国(HAS医疗申请表)程序),瑞士(BAG)和奥地利(MEL,OÖGKK)。根据已确定的8种特定国家模型,对德国,法国和瑞士在一定程度上可以与奥地利的医疗体系相媲美,此外还根据过程阶段(主题选择,评估,评估,决策,实施)和–方面(结构,决策标准,证据处理,利益相关者参与,结果沟通等)。

著录项

  • 作者

    Breyer E.;

  • 作者单位
  • 年度 2008
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号